: FDA advisers narrowly back accelerated approval of Sarepta gene therapy Posted on May 12, 2023 By Charlielikes FDA advisers vote 8-6 Friday to recommend the agency grant accelerated approval to Sarepta Therapeutics Inc.’s gene therapy for Duchenne muscular dystrophy. Stock Market Tags:‘back, accelerated, advisers, approval, billy wilkins, fda, gene, market, narrowly, of, sarepta, stock, stock market, therapy